AMGEN INC
AMGNNASDAQ$451.78▲ $3.81 (+0.85%)
Market closed · at closeTrack AMGN
Get earnings, price moves & breaking news on Telegram
24h▲ 0.8%
7d▲ 0.9%
14d▲ 4.1%
30d▲ 6.7%
ytd▲ 38.0%
1y▲ 54.8%
🏦Market Cap
$244.25B
Large Cap
📈Revenue Growth (YoY)
9.1%
Slowing
📊Gross Margin
74.3%
High
💵FCF Margin
28.1%
Strong
⚖️P/S Ratio
6.4x
Fair
Otter Score
76
Strong
AMGEN INC
AMGNAnalyst Ratings
Price
$451.78
Total
22
Raised
17
Lowered
5
Avg PT
$407.23
H / L
$500 / $230
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Scotiabank Amgen | Raised | Sector Outperform | 2026-09-29 | $500.00 | +10.70% |
Oppenheimer Amgen | Raised | Outperform | 2026-10-23 | $480.00 | +6.20% |
UBS Amgen | Raised | Buy | 2026-10-09 | $470.00 | +4.00% |
Argus Research Amgen | Raised | Buy | 2026-08-19 | $460.00 | +1.80% |
Piper Sandler Amgen | Raised | Overweight | 2026-08-20 | $457.00 | +1.20% |
TD Cowen Amgen | Raised | Buy | 2026-08-05 | $452.00 | +0.00% |
Goldman Sachs Amgen | Raised | Buy | 2026-08-05 | $450.00 | −0.40% |
Cantor Fitzgerald Amgen | Raised | Neutral | 2026-10-08 | $440.00 | −2.60% |
Wells Fargo Amgen | Lowered | Equal-Weight | 2026-10-12 | $430.00 | −4.80% |
RBC Capital Amgen | Raised | Outperform | 2026-10-08 | $430.00 | −4.80% |
HSBC Amgen | Lowered | Buy → Hold | 2026-09-10 | $425.00 | −5.90% |
BMO Capital Amgen | Lowered | Market Perform | 2026-10-12 | $415.00 | −8.10% |
Citigroup Amgen | Raised | Neutral | 2026-08-07 | $405.00 | −10.40% |
Barclays Amgen | Raised | Equal-Weight | 2026-10-21 | $400.00 | −11.50% |
Canaccord Genuity Amgen | Raised | Hold | 2026-08-05 | $384.00 | −15.00% |
Truist Securities Amgen | Raised | Hold | 2026-10-07 | $380.00 | −15.90% |
Guggenheim Amgen | Lowered | Neutral | 2026-10-13 | $378.00 | −16.30% |
Morgan Stanley Amgen | Lowered | Equal-Weight | 2026-10-07 | $359.00 | −20.50% |
Mizuho Amgen | Raised | Neutral | 2026-08-18 | $352.00 | −22.10% |
Bernstein Amgen | Raised | Market Perform | 2026-08-06 | $345.00 | −23.60% |
B of A Securities Amgen | Raised | Underperform | 2026-08-05 | $317.00 | −29.80% |
Baird Amgen | Raised | Underperform | 2026-08-05 | $230.00 | −49.10% |
Institution
Scotiabank
Raised · Sector Outperform · 2026-09-29
$500.00
+10.70%
Oppenheimer
Raised · Outperform · 2026-10-23
$480.00
+6.20%
UBS
Raised · Buy · 2026-10-09
$470.00
+4.00%
Argus Research
Raised · Buy · 2026-08-19
$460.00
+1.80%
Piper Sandler
Raised · Overweight · 2026-08-20
$457.00
+1.20%
TD Cowen
Raised · Buy · 2026-08-05
$452.00
+0.00%
Goldman Sachs
Raised · Buy · 2026-08-05
$450.00
−0.40%
Cantor Fitzgerald
Raised · Neutral · 2026-10-08
$440.00
−2.60%
Wells Fargo
Lowered · Equal-Weight · 2026-10-12
$430.00
−4.80%
RBC Capital
Raised · Outperform · 2026-10-08
$430.00
−4.80%
HSBC
Lowered · Buy → Hold · 2026-09-10
$425.00
−5.90%
BMO Capital
Lowered · Market Perform · 2026-10-12
$415.00
−8.10%
Citigroup
Raised · Neutral · 2026-08-07
$405.00
−10.40%
Barclays
Raised · Equal-Weight · 2026-10-21
$400.00
−11.50%
Canaccord Genuity
Raised · Hold · 2026-08-05
$384.00
−15.00%
Truist Securities
Raised · Hold · 2026-10-07
$380.00
−15.90%
Guggenheim
Lowered · Neutral · 2026-10-13
$378.00
−16.30%
Morgan Stanley
Lowered · Equal-Weight · 2026-10-07
$359.00
−20.50%
Mizuho
Raised · Neutral · 2026-08-18
$352.00
−22.10%
Bernstein
Raised · Market Perform · 2026-08-06
$345.00
−23.60%
B of A Securities
Raised · Underperform · 2026-08-05
$317.00
−29.80%
Baird
Raised · Underperform · 2026-08-05
$230.00
−49.10%
One row per institution · price target from the firm's latest published target